COVID-19 Prevalence and Mortality in Chronic Dialysis Patients.
作者信息
Hoxha Elion, Suling Anna, Turner Jan Eric, Haubitz Marion, Floege Jürgen, Huber Tobias B, Galle Jan-Christoph
出版信息
Dtsch Arztebl Int. 2021 Mar 19;118(11):195-196. doi: 10.3238/arztebl.m2021.0160.
Abstract
摘要
相似文献
1
COVID-19 Prevalence and Mortality in Chronic Dialysis Patients.慢性透析患者中的新冠病毒病患病率及死亡率
Dtsch Arztebl Int. 2021 Mar 19;118(11):195-196. doi: 10.3238/arztebl.m2021.0160.
2
SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience.严重急性呼吸综合征冠状病毒2与血液透析：患者及医护团队中的传播与死亡率。来自伦巴第地区经验的思考。
J Nephrol. 2021 Apr;34(2):277-279. doi: 10.1007/s40620-021-01003-3.
3
COVID-19-related stigma and perceived stress among dialysis staff.透析工作人员中与新冠病毒疾病相关的污名化及感知压力
J Nephrol. 2020 Dec;33(6):1121-1122. doi: 10.1007/s40620-020-00833-x.
4
[The COVID-19 pandemic and hemodialysis: a multicentric experience].[新型冠状病毒肺炎大流行与血液透析：多中心经验]
G Ital Nefrol. 2020 Dec 7;37(6):2020-vol6.
5
Home Dialysis: Lessons from COVID-19 and Other Viral Outbreaks.家庭透析：COVID-19及其他病毒爆发带来的经验教训
Saudi J Kidney Dis Transpl. 2020 Sep-Oct;31(5):1161. doi: 10.4103/1319-2442.301192.
6
Incidence and factors associated with COVID-19 in 13 hemodialysis units.13个血液透析单位中与新型冠状病毒肺炎相关的发病率及因素
Int Urol Nephrol. 2022 Mar;54(3):715-716. doi: 10.1007/s11255-021-02918-3. Epub 2021 Jun 18.
7
Surveillance and Isolation Based Strategies to Prevent COVID-19 in a Dialysis Center of Tehran, a Customized Approach.基于监测与隔离的策略在德黑兰一家透析中心预防新冠病毒病的定制方法
Iran J Kidney Dis. 2020 Jul;14(4):321-322.
8
[COVID-19 inside dialysis units].[透析单元内的新型冠状病毒肺炎]
Rev Med Liege. 2020;75(S1):41-47.
9
Managing the dialysis mode for people infected with COVID-19.为感染新冠病毒的患者管理透析模式。
Ren Fail. 2020 Nov;42(1):587-589. doi: 10.1080/0886022X.2020.1782230.
10
[Reception of patients with chronic renal failure, COVID-19].[慢性肾衰竭患者合并新型冠状病毒肺炎的收治]
Rev Infirm. 2021 May;70(271):41-42. doi: 10.1016/j.revinf.2021.03.017. Epub 2021 Apr 6.
引用本文的文献
1
Durability of Humoral Responses after an Adapted SARS-CoV-2 mRNA Vaccine Dose in Hemodialysis Patients.血液透析患者接种一剂适应性SARS-CoV-2 mRNA疫苗后体液免疫反应的持久性
Vaccines (Basel). 2024 Jul 3;12(7):738. doi: 10.3390/vaccines12070738.
2
Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis Patients.应对奥密克戎BA.5浪潮：慢性血液透析患者接种二价奥密克戎BA.4-5适配mRNA SARS-CoV-2疫苗后的体液免疫反应改善
Vaccines (Basel). 2023 Aug 28;11(9):1428. doi: 10.3390/vaccines11091428.
3
Intradialytic neuromuscular electrical stimulation with optional virtual reality distraction improves not only muscle strength and functional capacity but also serum albumin level in haemodialysis patients: a pilot randomized clinical trial.透析中神经肌肉电刺激结合可选虚拟现实分散注意力不仅改善血液透析患者的肌肉力量和功能容量，而且改善血清白蛋白水平：一项初步随机临床试验。
BMC Nephrol. 2023 Aug 23;24(1):246. doi: 10.1186/s12882-023-03283-2.
4
Antibody and T-Cell Responses against SARS-CoV-2 after Booster Vaccination in Patients on Dialysis: A Prospective Observational Study.透析患者加强接种新冠疫苗后针对严重急性呼吸综合征冠状病毒2的抗体和T细胞反应：一项前瞻性观察研究
Vaccines (Basel). 2023 Jan 25;11(2):260. doi: 10.3390/vaccines11020260.
5
Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort.血液透析患者与匹配队列对 SARS-CoV-2 疫苗的体液反应。
BMJ Open. 2022 Nov 8;12(11):e065741. doi: 10.1136/bmjopen-2022-065741.
6
Efficacy and Safety of COVID-19 Vaccine in Patients on Renal Replacement Therapy.新冠病毒疫苗在接受肾脏替代治疗患者中的有效性和安全性
Vaccines (Basel). 2022 Aug 25;10(9):1395. doi: 10.3390/vaccines10091395.
7
Effect of Third and Fourth mRNA-Based Booster Vaccinations on SARS-CoV-2 Neutralizing Antibody Titer Formation, Risk Factors for Non-Response, and Outcome after SARS-CoV-2 Omicron Breakthrough Infections in Patients on Chronic Hemodialysis: A Prospective Multicenter Cohort Study.基于mRNA的第三剂和第四剂加强疫苗接种对慢性血液透析患者中SARS-CoV-2中和抗体滴度形成、无应答危险因素及SARS-CoV-2奥密克戎突破性感染后结局的影响：一项前瞻性多中心队列研究
J Clin Med. 2022 Jun 2;11(11):3187. doi: 10.3390/jcm11113187.
8
BNT162b2 vaccine considerations for immunocompromised individuals: A global perspective.免疫功能低下个体的BNT162b2疫苗考量：全球视角
Ann Med Surg (Lond). 2022 Jun;78:103796. doi: 10.1016/j.amsu.2022.103796. Epub 2022 May 17.
9
SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality).慢性肾脏病合并透析患者的 SARS-CoV-2 感染：不同大流行期间的描述及对疾病进程（死亡率）的影响。
Infection. 2023 Feb;51(1):71-81. doi: 10.1007/s15010-022-01826-7. Epub 2022 Apr 29.
10
Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational study.血液透析患者中 ChAd/BNT 异源疫苗与同源 BNT/BNT 和 ChAd/ChAd SARS-CoV-2 疫苗相比的体液免疫原性和耐受性：一项多中心前瞻性观察研究。
J Nephrol. 2022 Jun;35(5):1467-1478. doi: 10.1007/s40620-022-01247-7. Epub 2022 Jan 27.
本文引用的文献
1
COVID-19 in patients undergoing long-term dialysis in Ontario.安大略省长期透析患者中的 COVID-19 病例。
CMAJ. 2021 Feb 22;193(8):E278-E284. doi: 10.1503/cmaj.202601. Epub 2021 Feb 4.
2
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA.慢性肾脏病是重症 COVID-19 的一个关键风险因素：ERA-EDTA 的行动呼吁。
Nephrol Dial Transplant. 2021 Jan 1;36(1):87-94. doi: 10.1093/ndt/gfaa314.
3
Kidney disease is associated with in-hospital death of patients with COVID-19.肾病与 COVID-19 患者住院期间的死亡相关。
Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.
Zotero 插件